Validating a minipig model to improve hearing treatments
Official title: Minipig Model Validation for Hearing Research and Drug and Device Development
Funded at Turner Scientific, LLC · NIH-11009813 · Data updated 2026-11-12
This study is looking at how to better deliver medications to the inner ear to help treat hearing loss, using minipigs to find out what works best, so that future treatments can be more effective for people like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Turner Scientific, LLC NIH-funded |
| Lab location | 1 site (Jacksonville, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,022,655 |
| NIH project number | 1R44DC022216-01 |
| Project ID | NIH-11009813 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing acquired hearing loss who may benefit from new therapeutic approaches.
✕Less likely to help
Patients with congenital hearing loss or those who do not respond to pharmacotherapy may not benefit from this research.
What this research studies
This research focuses on developing a minipig model to better understand how drugs can be effectively delivered to the inner ear for treating hearing loss. By using this large animal model, researchers aim to gather experimental data that can demonstrate how well drugs reach their intended targets within the cochlea. The study addresses the challenges faced by previous therapies that failed to distribute effectively in the human ear, which could lead to more successful treatments in the future. Patients may benefit from improved drug delivery methods that enhance the effectiveness of hearing restoration therapies.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for hearing loss by improving drug delivery to the inner ear.
How similar studies have gone: While there have been challenges in drug delivery for hearing loss, this approach using a minipig model is relatively novel and aims to address previously unmet needs in the field.
Where this research is happening
-
Turner Scientific, LLC
Jacksonville, United States Active
Researchers
- Principal investigator: Turner, Jeremy G — Turner Scientific, LLC
- Study coordinator: Turner, Jeremy G
Related research
Other NIH-funded projects on the same topics.
-
Improving Drug Delivery for Hearing Loss Treatments
This project aims to create a better animal model to help develop new medicines and devices for people with hearing loss.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.